Patient-informed clinical trial development with Victoria DiBiaso, VP & Global Head Patient Informed Development & Health Value Translation at Sanofi

Today’s episode features Victoria DiBiaso from Sanofi. Victoria provides a detailed analysis of patient-informed development and the critical importance of diversity and inclusion in clinical trials. With her unique perspective stemming from her nursing background, she explains the significance of patient-centric trials and the future of healthcare. 

Throughout the episode, Victoria elaborates on effective communication with patient communities, the significance of trust-building, and how understanding social determinants of health can aid in forging strong relationships with patient advisors. The episode further explores the world of drug development, from considering patient-relevant endpoints to health scales and label opportunities.  

 Topics Discussed: 

• (00:00:00) Introduction
• (00:00:51) Victoria’s background and how she ended up in her current role 
• (00:02:32) An explanation of patient-informed development 
• (00:03:48) The meaning of patient centricity 
• (00:06:13) Stumbling blocks to patient centricity 
• (00:08:14) What cross-industry collaboration is like 
• (00:09:41) Cross-industry collaboration milestones 
• (00:12:07) The new voice Victoria wants to bring forward 
• (00:16:56) How the new programs will fit into patients’ lives 
• (00:18:48) How to talk about clinical trials in language patients want to hear 
• (00:19:53) Important factors in implementing patient-centric solutions in clinical trial programs 
• (00:21:24) Victoria’s thinking about what parts of patient disease strategy are shareable and standardizable 
• (00:23:28) What the future of patient-centric clinical trials looks like 
• (00:25:16) What modern patient recruitment means  
• (00:26:53) How Victoria would change clinical trials overnight if she had a magic wand 
• (00:29:44) How to learn more about what Victoria is doing 
  

Links:  

Victoria DiBiaso